Cite
HARVARD Citation
Chen, Y. et al. (2016). Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors. BMC cancer. 16 (1), pp. 1-7. [Online].